Skip to main content
. Author manuscript; available in PMC: 2023 May 21.
Published in final edited form as: Endocr Pract. 2022 Aug 11;28(10):923–1049. doi: 10.1016/j.eprac.2022.08.002
Goals of therapy in persons with prediabetes and metabolic syndrome
✓ Prevent progression to T2D
✓ Prevent progression to NASH
✓ Improve CVD risk factors via aggressive control of:
  • elevated BP
  • LDL-C
  • dyslipidemia
✓ Treat obesity or prevent excessive weight gain
✓ Improve functionality and
✓ QoL